Mind Medicine (MNMD) has released an update.
Mind Medicine (MindMed) Inc., a biopharmaceutical company focused on brain health disorders, has announced their participation in the upcoming 34th Annual Oppenheimer Healthcare Life Sciences Conference. This event will feature a presentation by MindMed’s management team and will be available for replay on their Investor Relations website for 90 days.
For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.
